Owlet, Inc. operates as a digital parenting platform in the United States. The company's platform focuses on giving real-time data and insights to parents. Its products include Owlet Monitor Duo that gets the snapshot of baby's wellbeing; Owlet Smart Sock that tracks baby's heart rate and oxygen while sleeping and get notifications if baby needs to be checked on; Owlet Cam, a smart HD video baby monitor; and Dream Lab, an online and personalized infant sleep solution. The company was founded in 2012 and is based in Lehi, Utah.
IPO Year: 2020
Exchange: NYSE
Website: owletcare.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/6/2021 | $12.00 → $5.00 | Neutral | Citigroup |
| 10/5/2021 | $8.50 → $5.50 | Buy → Neutral | BofA Securities |
| 9/8/2021 | $8.50 | Buy | BofA Securities |
| 8/5/2021 | $11.00 | Neutral | Citigroup |
4 - Owlet, Inc. (0001816708) (Issuer)
4 - Owlet, Inc. (0001816708) (Issuer)
4 - Owlet, Inc. (0001816708) (Issuer)
4 - Owlet, Inc. (0001816708) (Issuer)
4 - Owlet, Inc. (0001816708) (Issuer)
4 - Owlet, Inc. (0001816708) (Issuer)
4 - Owlet, Inc. (0001816708) (Issuer)
4 - Owlet, Inc. (0001816708) (Issuer)
4 - Owlet, Inc. (0001816708) (Issuer)
4 - Owlet, Inc. (0001816708) (Issuer)
10-Q - Owlet, Inc. (0001816708) (Filer)
8-K - Owlet, Inc. (0001816708) (Filer)
8-K - Owlet, Inc. (0001816708) (Filer)
8-K - Owlet, Inc. (0001816708) (Filer)
424B5 - Owlet, Inc. (0001816708) (Filer)
FWP - Owlet, Inc. (0001816708) (Subject)
424B5 - Owlet, Inc. (0001816708) (Filer)
8-K - Owlet, Inc. (0001816708) (Filer)
EFFECT - Owlet, Inc. (0001816708) (Filer)
8-K - Owlet, Inc. (0001816708) (Filer)
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), a pioneer of smart baby monitoring, is on a mission to raise critical funds for research that could bring an end to sudden infant death syndrome (SIDS). Owlet is partnering in this effort with Dr. Carmel Harrington, Honorary Research Fellow at Sydney Children's Hospital Westmead, and Elisha Palmer of Knox Blocks Foundation, both of whom are parents that have lost a child to SIDS. Sudden unexpected infant death (SUID), which includes SIDS, claims the lives of more than 3,000 babies each year in the U.S. alone1. The rate of SIDS is on the rise in the U.S.2 – making it one of the leading causes of infant mortality3. Despite this, there is m
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), a pioneer of smart baby monitoring, today announces the appointment of Marc Stoll to the Company's Board of Directors. Stoll is currently an Investment Partner at Eclipse, a strategic investment firm focused on advancing the Industrial Evolution. His experience spans more than 25 years across the global finance and technology industries, and his expertise in leading corporate strategy and operational excellence will help bolster Owlet's future ventures and growth potential. "I'm thrilled to join Owlet's Board of Directors after spending time becoming very familiar with the brand and products, its life-changing mission and amazing custome
Owlet, Inc. (NYSE:OWLT, "the Company"))), the pioneer of smart baby monitoring, is pleased to announce the addition of Melissa Gonzales to the Company's Board of Directors. Gonzales brings more than 20 years of consumer and provider healthcare experience to Owlet, further advancing the Company as a leader in infant monitoring solutions. "Owlet's growth proposition to facilitate change in health equity through its innovation in connected digital monitoring is extremely exciting," said Melissa Gonzales. "Creating meaningful momentum and impact within these trends is important to me personally and professionally and I am looking forward to contributing my experience towards supporting Owlet'
Citigroup reiterated coverage of Owlet with a rating of Neutral and set a new price target of $5.00 from $12.00 previously
BofA Securities downgraded Owlet from Buy to Neutral and set a new price target of $5.50 from $8.50 previously
BofA Securities initiated coverage of Owlet with a rating of Buy and set a new price target of $8.50
Citigroup initiated coverage of Owlet with a rating of Neutral and set a new price target of $11.00
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today reports financial results for the third quarter ended September 30, 2024. Owlet's Chief Executive Officer and Co-Founder, Kurt Workman, President and Chief Revenue Officer, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call to review the Company's results and provide a business update today, November 13, 2024, at 4:30 p.m. ET. Q3 2024 Financial Highlights: Q3 Revenue of $22.1 million, up 141% from Q3 2023 Q3 Gross Margin of 52.2%, up 1,590 basis points from Q3 2023 Q3 Net Loss of $(5.6) million, compared to $(5.6) million in Q3 2023 Q3
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, announced today the participation in two upcoming investor conferences. Information on the conferences can be found below. Sidoti Micro Cap Conference BTIG Digital Health Forum Sidoti Micro Cap Conference Owlet will participate in the Sidoti Micro Cap Conference, being held virtually on Thursday, November 14, 2024. Kurt Workman, Owlet's Chief Executive Officer and Co-Founder, and Amanda Twede Crawford, Chief Financial Officer, are scheduled to present at 12:15 p.m. ET. In conjunction with the event, Owlet executives will also be available to participate in one-on-one meetings with investors re
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, plans to announce third quarter 2024 financial results after market close on Wednesday, November 13, 2024. Owlet's Chief Executive Officer and Co-Founder, Kurt Workman, President and Chief Revenue Officer, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call at 4:30 p.m. ET the same day to discuss these results and provide a business update. Participants may access the call at 833-470-1428 (domestic) or 404-975-4839 (international) and reference Access Code 626609. A simultaneous webcast may be accessed online at the Events section of Owlet's Investor Rela
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), a pioneer of smart infant monitoring, today announced that it has received formal notice from the New York Stock Exchange ("NYSE") that the Company has regained compliance with the NYSE's continued listing standards. As previously disclosed, on April 4, 2023, Owlet was notified by the NYSE that the Company was not in compliance with Section 802.01B of the NYSE Listed Company Manual because its average global market capitalization over a consecutive 30-day trading day period was less than $50 million and, at the same time, its last reported stockholders' equity was less than $50 million. As a result of the Company's achievement of complian
The study, conducted by Owlet, brings attention to the public health issue of parental mental health and the challenges of stress, anxiety, and sleep deprivation. Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today released its State of Parenting Report, which reveals the immense pressure parents face during their baby's first year of life. On average, parents lose three hours of sleep per night,1 contributing to higher levels of stress and fatigue. With 126 million pediatric visits every year,2 it's clear that health concerns also weigh heavily on parents' minds. The number one reason for these visits is respiratory infections,3 and parents re
The Company closed on $11.6 million in proceeds from the underwritten public offering and up to $35 million in proceeds from the debt refinancing. Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today announced the closing of its underwritten public offering of 3,135,136 shares of the Company's Class A common stock (the "Offering"). The shares of Class A common stock were sold at a public offering price of $3.70 per share, before underwriting discounts and commissions. All of the shares in the Offering were sold by the Company. The gross proceeds to Owlet from the Offering were approximately $11.6 million, before deducting underwriting discounts
The Company anticipates receiving $11.6 million in proceeds from the underwritten public offering and up to $35 million in proceeds from the debt refinancing. Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today announced the pricing of an underwritten public offering of 3,135,136 shares of the Company's Class A common stock (the "Offering"). The shares of Class A common stock are being sold at a public offering price of $3.70 per share, before underwriting discounts and commissions. All of the shares in the Offering are to be sold by the Company. The gross proceeds to Owlet from the Offering are expected to be approximately $11.6 million, befor
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today announced it intends to offer and sell its Class A common stock in an underwritten public offering. In addition, the Company intends to grant the underwriter a 30-day option to purchase up to an additional 15% of the gross proceeds of its Class A common stock at the public offering price per share, before underwriting discounts and commissions. All of the shares in the proposed offering are to be sold by the Company. Owlet intends to use the net proceeds from the proposed public offering for general corporate purposes, capital expenditures, working capital and general and administrative expens
Owlet debuts new Dream Sock at Kind + Jugend 2024 and shares that the device will soon be available to even more parents across the globe. Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, announced today at Kind + Jugend in Cologne, Germany, that medically-certified Dream Sock will soon be available in even more countries, including Poland, Greece, and the Czech Republic. Dream Sock is the Company's medically-certified baby monitor accessible across Europe, giving parents safe and accurate health readings and actionable alarms while their baby sleeps. This press release features multimedia. View the full release here: https://www.businesswire.co
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today reports financial results for the second quarter ended June 30, 2024. Owlet's Chief Executive Officer and Co-Founder, Kurt Workman, President and Chief Revenue Officer, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call to review the Company's results and provide a business update today, August 12, 2024, at 4:30 p.m. ET. Q2 2024 Financial Highlights: Obtained CE Medical certification for UK and Europe, launching Dream Sock across major European markets. Q2 Revenue was approximately $20.7 million, up approximately 58% year over year. Q2 Gr
SC 13G/A - Owlet, Inc. (0001816708) (Subject)
SC 13D/A - Owlet, Inc. (0001816708) (Subject)
SC 13D/A - Owlet, Inc. (0001816708) (Subject)
SC 13D/A - Owlet, Inc. (0001816708) (Subject)
SC 13G/A - Owlet, Inc. (0001816708) (Subject)
SC 13G/A - Owlet, Inc. (0001816708) (Subject)
SC 13D/A - Owlet, Inc. (0001816708) (Subject)
SC 13G - Owlet, Inc. (0001816708) (Subject)
SC 13D - Owlet, Inc. (0001816708) (Subject)
SC 13D/A - Owlet, Inc. (0001816708) (Subject)
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today reports financial results for the third quarter ended September 30, 2024. Owlet's Chief Executive Officer and Co-Founder, Kurt Workman, President and Chief Revenue Officer, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call to review the Company's results and provide a business update today, November 13, 2024, at 4:30 p.m. ET. Q3 2024 Financial Highlights: Q3 Revenue of $22.1 million, up 141% from Q3 2023 Q3 Gross Margin of 52.2%, up 1,590 basis points from Q3 2023 Q3 Net Loss of $(5.6) million, compared to $(5.6) million in Q3 2023 Q3
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, plans to announce third quarter 2024 financial results after market close on Wednesday, November 13, 2024. Owlet's Chief Executive Officer and Co-Founder, Kurt Workman, President and Chief Revenue Officer, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call at 4:30 p.m. ET the same day to discuss these results and provide a business update. Participants may access the call at 833-470-1428 (domestic) or 404-975-4839 (international) and reference Access Code 626609. A simultaneous webcast may be accessed online at the Events section of Owlet's Investor Rela
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today reports financial results for the second quarter ended June 30, 2024. Owlet's Chief Executive Officer and Co-Founder, Kurt Workman, President and Chief Revenue Officer, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call to review the Company's results and provide a business update today, August 12, 2024, at 4:30 p.m. ET. Q2 2024 Financial Highlights: Obtained CE Medical certification for UK and Europe, launching Dream Sock across major European markets. Q2 Revenue was approximately $20.7 million, up approximately 58% year over year. Q2 Gr
Owlet to Report Second Quarter 2024 Financial Results on August 12, 2024 Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today announced that Kate Scolnick, Chief Financial Officer ("CFO"), will be departing the Company to pursue other opportunities. Amanda Twede Crawford, Owlet's Vice President, Financial Planning and Analysis, will assume the role of CFO. Kate will remain at the Company in an advisory role for a transition period through September 2024. "On behalf of the Board of Directors and Owlet, I want to thank Kate for her executive leadership and significant contributions since joining our management team prior to our initial public l
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today reports financial results for the first quarter ended March 31, 2024. Owlet's Chief Executive Officer and Co-Founder, Kurt Workman, President and Chief Revenue Officer, Jonathan Harris, and Chief Financial Officer, Kate Scolnick, will host a conference call to review the Company's results and provide a business update today, May 6, 2024, at 4:30 p.m. ET. Q1 2024 Financial Highlights: Q1 Revenue was approximately $14.8 million, up approximately 37% year over year. Q1 Gross Margin was approximately 44.4%, up 570 basis points year over year. Q1 Net Income was approximately $3.3 million,
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, will release its first quarter 2024 financial results after the market closes on May 6, 2024. Owlet will issue a copy of the earnings release via Business Wire and include a copy on Owlet's Investor Relations website at investors.owletcare.com. Owlet's Chief Executive Officer, Kurt Workman, President and Chief Revenue Officer, Jonathan Harris, and Chief Financial Officer, Kate Scolnick, will host a conference call that same day at 4:30 p.m. ET to discuss these results and provide a business update. To access the conference call by telephone, please dial (833) 470-1428 (domestic) or +1 (404) 975-483
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today reported financial results for the fourth quarter and fiscal year ended December 31, 2023. Owlet's Chief Executive Officer and Co-Founder, Kurt Workman, and Chief Financial Officer, Kate Scolnick, will host a conference call to review the Company's results and provide a business update today, March 7, 2024, at 4:30 p.m. ET. Q4 2023 Financial Highlights Q4 Revenue was approximately $21.0 million. Q4 Gross Margin was approximately 47.1%. Q4 Net Loss was approximately $6.9 million, down 65% from $19.5 million year over year. Q4 adjusted EBITDA loss was approximately $0.7 million, dow
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today announces the following preliminary unaudited results for the fourth quarter 2023. Preliminary Unaudited Q4 2023 Financial Highlights Q4 Gross Sales is expected to be approximately $32.9 million, up 114% year over year. Q4 Net Revenue is expected to be approximately $21.0 million, up 75% year over year. Q4 Gross Margin is expected to be approximately 47%, up over 1,900 basis points from 27.8% year over year. Q4 Net Loss is expected to be approximately $6.9 million, down 65% from $19.5 million year over year. Q4 adjusted EBITDA loss is expected to be approximately $0.7 million,
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT) today reported financial results for the third quarter ended September 30, 2023. Owlet's Chief Executive Officer, Kurt Workman, and Chief Financial Officer, Kate Scolnick, will host a conference call to review the Company's results and provide a business update today, November 13, 2023, at 4:30 p.m. ET. Q3 2023 Highlights and Recent Developments Achieved de novo FDA- authorization for Dream Sock® – the first and only over-the-counter, medical grade pulse oximeter classified by FDA for healthy infants and preparing for launch by December 2023. Achieved revenues of $9.2 million as the Company entered into a new arrangement to start se
Owlet, Inc. ("Owlet") (NYSE:OWLT) will release its third quarter 2023 results after the market closes on November 13, 2023. Owlet will issue a copy of the earnings release via Business Wire and include a copy on Owlet's Investor Relations website at investors.owletcare.com. Owlet's Chief Executive Officer, Kurt Workman, and Chief Financial Officer, Kate Scolnick, will host a conference call that same day at 4:30 p.m. ET to discuss these results and provide a business update. To access the conference call by telephone, please dial (833) 470-1428 (domestic) or +44 208-068-2558 (international) and reference Access Code 627533. To listen to the conference call via live audio webcast, please v
Owlet (NYSE:OWLT) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate of $(0.14) by 178.57 percent. The company reported quarterly sales of $14.800 million which missed the analyst consensus estimate of $16.430 million by 9.92 percent. This is a 38.32 percent increase over sales of $10.700 million the same period last year.
Parents will soon have access to Owlet's Dream Sock with medically-certified CE-Marking across the European marketsOwlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, announces the EU medical device certification of Dream Sock. This EU-CE-Mark certification, issued by Owlet's EU notified body, signifies that Owlet's Dream Sock has been assessed and certified to meet safety and health requirements set out under EU medical device legislation. With this certification, Owlet plans to expand its medical-device product portfolio to even more caregivers around the world.This EU medical device certification follows two marketing authorizations from the U.S. Fo
The partnership is set to transform infant care by providing virtual telehealth services to caregivers, increasing access to innovative medical-grade monitoring.Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, announces a strategic partnership with Wheel, an industry leader in providing virtual patient-centric care. Through this partnership, Wheel clinicians will provide caregivers of infants with timely prescriptions for BabySat™, Owlet's FDA-cleared infant pulse oximeter, ushering in a new era of digital healthcare solutions for families.Annually, more than 450,000 babies transition home from the neonatal intensive care unit (NICU)1. Further, ever
Owlet (NYSE:OWLT) reported its Q4 earnings results on Thursday, March 7, 2024 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Owlet missed estimated earnings by -200.0%, reporting an EPS of $-0.12 versus an estimate of $-0.04. Revenue was up $9.00 million from the same period last year. Past Earnings Performance Last quarter the company missed on EPS by $0.34 which was followed by a 8.0% drop in the share price the next day. Here's a look at Owlet's past performance: Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022 EPS Estimate -0.36 -0.72 -1.26 -2.10 EPS Actual -0.70 -0.56 -1.12 -1.96 Revenue Estimate 16.42M 14.38M 10.88M 12.92M Revenue Actual 9.20M 13.1
Owlet (NYSE:OWLT) reported quarterly losses of $(0.120) per share which missed the analyst consensus estimate of $(0.040) by 200 percent. The company reported quarterly sales of $21.000 million which missed the analyst consensus estimate of $21.160 million by 0.76 percent. This is a 75.00 percent increase over sales of $12.000 million the same period last year.
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million. • Stevanato Gr (NYSE:STVN) is likely to report quarterly earnings at $0.21 per share on revenue of $354.31 million. • ABM Indus (NYSE:ABM) is projected to report quarterly earnings at $0.71 per share on revenue of $2.01 billion. • Bilibili (NASDAQ:BILI) is likely to report quarterly loss at $0.22 per share on revenue of $887.26 million. • BJ's Wholesale Club (NYSE:BJ) is projected to report quarterly earnings at $1.06 per share on revenue of $5.39 billion. • Burlington Stores (NYSE:BURL) is estimated to report quarterly earnings at $3.30 per